Iproteos is featured in a recent issue of “Innovadores”, a supplement from “El Mundo” newspaper, which has been dedicated to IRB Barcelona, emphasizing the effort on technology transfer and highlighting the three spin-off companies which have come out of IRB … Continue reading
Iproteos has been selected as one of the Spanish finalists for the 2012 RedEmprendia prize for best spin-off project from a University (‘Premio RedEmprendia de la Universidad a la Empresa’). A total of 15 finalists (seven projects from Spanish Universities … Continue reading
Iproteos, which was founded last year by Dr. Tarragó and Prof. Giralt – research associate and group leader, respectively, at the IRB Chemistry and Molecular Pharmacology Program – is featured in the IRB 2011 Annual Report. In the institutional video … Continue reading
Iproteos is present at the 7th International Symposium on Neuroprotection and Neurorepair 2012 in Potsdam (Germany) from May 2nd to May 5th, joining experts in the field of stroke as well as Parkinson’s and Alzheimer’s disease to discuss recent scientific … Continue reading
The scientists of Iproteos will be present at the workshop organized by the European Federation for Medicinal Chemistry (EFMC) in Oegsteest (The Netherlands), which will be focused on the current safety and toxicity tests in pre-clinical and clinical studies.
Iproteos will be present at Europeptides 2011 in Berlin next November.